Document Detail


Intraperitoneal therapy for ovarian cancer: analysis of fluid distribution by computerized tomography.
MedLine Citation:
PMID:  1606086     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nineteen patients with ovarian cancer and minimal residual or persistent disease who were treated with cisplatin or carboplatin-based intraperitoneal (IP) regimens had distribution studies of IP contrast and computerized tomography prior to and during treatment. The distribution pattern was assessed retrospectively and scored for the presence of contrast in each of eight regions: the under surface of right and left diaphragms, the right and left paracolic gutters, the lesser omental sac, the intramesenteric region and the true and false pelvis. Assigning a point to each region with adequate distribution, we classified 10 patients to an excellent pattern (greater than or equal to 7 of 8 regions), 6 to a good pattern (5 to less than 7 regions), and 3 to an inadequate distribution pattern (less than 5 regions). Serial studies were performed in 8 patients after more than 4 cycles of IP therapy. In these patients, all of whom were tolerating treatment without progression, the distribution remained virtually unchanged for those with excellent distribution. One of three with good distribution manifested inadequate distribution on repeat study, and one of two with inadequate distribution improved to show a good pattern. In this small study there was no correlation of distribution patterns with plasma CA-125 at onset of IP treatment and prior surgical procedures or placement of the catheter tip. However, three patients with unsatisfactory patterns had procedures consisting of catheter placement only rather than formal reassessment laparotomies for ovarian cancer. Since satisfactory IP distribution may be required for obtaining a therapeutic advantage from IP therapy, methods for its assessment must be developed.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
F M Muggia; E LePoidevin; S Jeffers; C Russell; W Boswell; C P Morrow; J Curtin; J Schlaerth
Related Documents :
20692116 - Radiologically placed tunneled peritoneal catheter in palliation of malignant ascites.
2043876 - Percutaneous insertion of subclavian hickman catheters.
21055746 - Enhancement balloon vaginoplasty for treatment of blind vagina due to androgen insensit...
17437586 - A left-sided accessory pathway revisited with remote retrograde magnetic navigation.
16452706 - Language and cultural barriers in the assessment of enemy prisoners of war and other fo...
23679026 - Long-gap esophageal atresia: traction-growth and anastomosis - before and beyond.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  3     ISSN:  0923-7534     ISO Abbreviation:  Ann. Oncol.     Publication Date:  1992 Feb 
Date Detail:
Created Date:  1992-07-17     Completed Date:  1992-07-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  149-54     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Southern California, Los Angeles.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Ascitic Fluid / metabolism*
Female
Humans
Injections, Intraperitoneal
Ovarian Neoplasms / drug therapy*,  metabolism
Tomography, X-Ray Computed
Grant Support
ID/Acronym/Agency:
R01/CA 50412-02/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pretransplant conditioning with busulfan and cyclophosphamide in acute leukemia patients: neurologic...
Next Document:  Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed...